Search hospitals > California > Palo Alto
Lucile Packard Children's Hospital Stanford University
Claim this profilePalo Alto, California 94304
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Brain Tumor
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Neuroblastoma
418 reported clinical trials
42 medical researchers
Summary
Lucile Packard Children's Hospital Stanford University is a medical facility located in Palo Alto, California. This center is recognized for care of Leukemia, Tumors, Brain Tumor, Lymphoblastic Leukemia-Lymphoma, Neuroblastoma and other specialties. Lucile Packard Children's Hospital Stanford University is involved with conducting 418 clinical trials across 728 conditions. There are 42 research doctors associated with this hospital, such as Jay Michael S. Balagtas, Gail L Wright, MD, Sonia Partap, MD, and Norman J. Lacayo, MD.Area of expertise
1Leukemia
Global LeaderStage II
Philadelphia chromosome positive
Stage I
2Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
Jay Michael S. BalagtasLucile Packard Children's Hospital Stanford University7 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
48 reported clinical trials
100 drugs studied
Gail L Wright, MDFlorida Cancer Specialists - North Region4 years of reported clinical research
Studies Breast Cancer
Studies Colorectal Cancer
9 reported clinical trials
19 drugs studied
Sonia Partap, MDLucille Packard Children's Hospital at Stanford University Medical Center4 years of reported clinical research
Studies Brain Tumor
Studies Medulloblastoma
8 reported clinical trials
14 drugs studied
Norman J. Lacayo, MDLucile Packard Children's Hospital Stanford University7 years of reported clinical research
Studies Leukemia
Studies Acute Myeloid Leukemia
7 reported clinical trials
34 drugs studied
Clinical Trials running at Lucile Packard Children's Hospital Stanford University
Brain Tumor
Astrocytoma
Osteosarcoma
Diffuse Intrinsic Pontine Glioma
Tumors
Acute Lymphoblastic Leukemia
Neuroblastoma
Recurrence
Low Grade Glioma
Non-Hodgkin's Lymphoma
Selumetinib + Vinblastine
for Low-Grade Glioma
This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
Selumetinib vs Carboplatin/Vincristine
for Brain Cancer
This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and vincristine.
Recruiting2 awards Phase 328 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Lucile Packard Children's Hospital Stanford University?
Lucile Packard Children's Hospital Stanford University is a medical facility located in Palo Alto, California. This center is recognized for care of Leukemia, Tumors, Brain Tumor, Lymphoblastic Leukemia-Lymphoma, Neuroblastoma and other specialties. Lucile Packard Children's Hospital Stanford University is involved with conducting 418 clinical trials across 728 conditions. There are 42 research doctors associated with this hospital, such as Jay Michael S. Balagtas, Gail L Wright, MD, Sonia Partap, MD, and Norman J. Lacayo, MD.
Where is Lucile Packard Children's Hospital Stanford University located?
Lucile Packard Children's Hospital Stanford is located at 725 Welch Road, Palo Alto, CA 94304. It is part of the Stanford University Medical Center. The main entrance is accessible from Welch Road.
Who should I call to ask about financial aid or insurance network?
**Lucile Packard Children's Hospital Stanford University - Financial Assistance and Insurance Inquiries**
**Financial Assistance:**
- **Phone:** 844-498-2900 (Monday – Friday, 8:00 a.m. – 5:00 p.m.)
- **Mail:** SHC Patient Financial Assistance, Patient Financial Services, P.O. BOX 740715, Los Angeles, CA 90074-0715
**Financial Counseling:**
- **Phone:** 650-736-2273
- **Details:** Contact the Financial Counseling Team to discuss financial assistance applications.
For additional support, visit the Stanford Medicine Children's Health Financial Assistance Application page.
What insurance does Lucile Packard Children's Hospital Stanford University accept?
Lucile Packard Children's Hospital Stanford University accepts a range of insurance plans, such as Anthem Blue Cross, Medi-Cal Fee For Service, and Blue Shield of California. As part of the Stanford Health Care network, it has agreements with numerous health plans and medical groups. For the most accurate and current information on accepted insurance plans, contact the hospital directly.
What awards or recognition has Lucile Packard Children's Hospital Stanford University received?
Lucile Packard Children's Hospital Stanford is celebrated as one of the 100 great hospitals in the nation by Becker's Hospital Review and has earned Magnet® Recognition for outstanding nursing practice, teamwork, and patient care. It consistently ranks in the top 20 of all children's hospitals by U.S. News & World Report. The hospital is renowned for its excellence in neonatology, nephrology, pulmonology, and endocrinology.